Drugs.com

FEBRUARY 16, 2025

SUNDAY, Feb. 16, 2025 -- Flu season is in full swing, making it more important than ever to take steps to protect yourself and your loved ones.Dr. Priya Soni, a pediatric infectious disease specialist at Cedars-Sinai Guerin Childrens Health Center.

Disease 266

Disease 266

SugarCone Biotech

FEBRUARY 16, 2025

There were waves of interest in this therapeutic space at ASCO in June 2024 and around the JP Morgan healthcare conference in January 2025. Here we take a look at the hope and the hype behind the PD1/VEGF bispecific therapeutics.

95

95

Drug Patent Watch

FEBRUARY 16, 2025

The Future of Biosimilars: Switching Strategies for Success As the biosimilar market continues to grow, pharmaceutical companies are looking for innovative ways to stay ahead of the competition. One strategy that's gaining traction is biosimilar-to-biosimilar switching. But what does this mean, and how can you make it work for your business? Biosimilar-to-biosimilar switching involves switching patients from one biosimilar to another, often to improve efficacy, reduce costs, or enhance patient o

Biosimilars 94

Biosimilars Pharmaceutical Companies Treatment Marketing 94

Codon

FEBRUARY 16, 2025

This article is best experienced on our website. In the late 1990s, a young physicist named Michael Elowitz decided to “program” living cells. A graduate student at Princeton University, Elowitz was spending a great deal of his free time poring over esoteric papers about circadian clocks, the molecular networks that control an organism’s behavior in roughly 24-hour cycles. “And as I’m reading all of these papers,” he told Asimov Press , “I noticed that m

DNA 80

DNA RNA Engineering Small Molecule 80

Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!

Clinical Trials